NurExone Biologic Inc. (id:1873 NRX)
3.00 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/25/2024 8:47:17 AM)
Exchange closed, opens in 42 minutes
-11.11 CAD (-11.11%)
-15.79 CAD (-15.79%)
-4.48 CAD (-4.48%)
-8.57 CAD (-8.57%)
116.95 CAD (116.95%)
39.13 CAD (39.13%)
About NurExone Biologic Inc.
Market Capitalization 55.30M
NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.
| Headquarters (address) |
1 First Canadian Place Toronto M5X 1G5 ON Canada |
| Phone | |
| Website | https://nurexone.com |
| Employees | 8 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | NRX |
| Exchange | Toronto Stock Exchange Venture |
| Currency | CAD |
| 52 week range | 3.00 - 1.19 |
| Market Capitalization | 55.30M |
| P/E trailing | -7.90 |
| P/E forward | -4.33 |
| Price/Book | 195.00 |
| Beta | 5.00 |
| EPS | 3.00 |
| EPS Canada (ID:82, base:720) | 2.18 |